Literature DB >> 25247673

Rapid progression of primary cutaneous gamma-delta T-cell lymphoma with an initial indolent clinical presentation.

Riley E Alexander1, Alden R Webb, Mohammad Abuel-Haija, Magdalena Czader.   

Abstract

Primary cutaneous gamma-delta T-cell lymphoma (CGD-TCL) is a rare cutaneous T-cell lymphoma characterized by a rapidly progressive clinical course and a poor prognosis. We report a case of a 52-year-old man with a 10-year history of erythematous nodules and a rapid terminal progression diagnosed as CGD-TCL. Biopsies taken at the time of progression showed a dense lymphocytic infiltrate involving the subcutaneous adipose tissue and deep dermis. One of the biopsies displayed much more limited involvement by CGD-TCL that was nearly identical to the biopsies of the erythematous lesions 10 years before. In conclusion, this case demonstrates a case of CGD-TCL presenting as a longstanding indolent disease with a rapid terminal progression. The indolent clinical course and histological heterogeneity make diagnosing this entity during the initial stage extremely challenging. This case underscores a diverse clinical presentations and a need to consider CGD-TCL in patients showing subcutaneous lesions with an indolent clinical course.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25247673     DOI: 10.1097/DAD.0b013e318289c9b8

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Primary Cutaneous Gamma-Delta T-Cell Lymphoma Initially Diagnosed as Subcutaneous Panniculitis-like T-Cell Lymphoma with Dermatomyositis.

Authors:  Chika Hirata; Kozo Nakai; Yusuke Kurasawa; Naoki Maekawa; Shuichi Kuniyuki; Keiko Yamagami; Masahiko Ohsawa; Daisuke Tsuruta
Journal:  Dermatopathology (Basel)       Date:  2022-04-29

2.  Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases.

Authors:  Mehdi Khallaayoune; Florent Grange; Morgane Condamina; Vanessa Szablewski; Bernard Guillot; Olivier Dereure
Journal:  Acta Derm Venereol       Date:  2020-01-23       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.